Polio Vaccines

/Polio Vaccines
­

Polio Vaccine Causes Polio

The risk of acquiring polio naturally in the Western Hemisphere is currently zero, and has been for many years. All cases of polio in the United States since 1979 have been caused by the polio vaccine. Between 1980-1985, 51 polio cases documented (out of a total of 55) were caused by the vaccine itself. Vaccination campaigns have been associated with significant increases (outbreaks) of vaccine-derived poliovirus (VDPV) throughout the world, (Haiti 2002, Oman 1988 and 1989, Gambia 1986)

Polio Vaccine and SV40 Contamination

The Simian (monkey) Virus known as SV40 was also present in US polio vaccines from 1954 to 1962. SV40 has been proven to be carcinogenic after scientists found it in certain types of human cancers. An analysis presented at the Vaccine Cell Substrate Conference in 2004 suggested that polio vaccines used in the former Soviet bloc countries, China, Japan, and Africa could have been contaminated up to 1980, meaning that hundreds of millions more could have been exposed to the SV40 virus.

Adverse Reactions

Besides vaccine-derived paralytic poliomyelitis (VAPP), the polio vaccine has been proven to cause acute flaccid paralysis, Guillain Barre syndrome, cancer, demyelination,

There is NO Polio in the Western Hemisphere

There have been no naturally occurring cases of polio since 1979 in the United States. The last case of paralytic polio in the Americas was found in Peru in1991.

Polio a Benign Disease in Majority of Healthy People

Most cases (up to 98%) occur without any apparent symptoms or with cold-like symptoms. Immunosuppression plays more of a role in paralytic polio than anything else.

Vaccine Failure

The polio vaccine has failed, many, many times to prevent polio in the vaccinated. This is well documented in the scientific literature.

Polio Vaccine Causes Polio

If the vaccine causes the disease it was meant to prevent, it cannot – at least in these victims — be deemed “effective.”

Unnecessary Interventions

Even where sanitation and nutrition are poor, polioviruses are widespread and nearly everyone develops antibodies. Epidemics are virtually unknown. Improvements in sanitation and nutrition are the smartest and safest measures to promote declines of polio. In 1982, a Taiwan polio outbreak (of a highly vaccinated population) revealed that children were five times more likely to contract polio if they drank from a contaminated, non-municipal water source.

Polio Vaccination Had Nothing to do with Disease Decline

Polio was already on the decline when vaccination campaigns began. In the United States and England, the incidence of death had already significantly declined between 1923-1953, before polio vaccinations (47% and 55%, respectively). After polio vacination campaigns, the overall incidence continued to decline — but they declined in countries that did not have widespread use of polio vaccination.

Statistical Manipulation

Walene James, in her excellent book Immunization: The Reality Behind the Myth, reveals how the medical profession altered diagnostic criteria and changed reporting practices to prove vaccine efficacy.

 

Polio Vaccines by Brand

Imovax Polio Inactivated Poliomyelitis Vaccine (VERO)
Manufacturer Aventis Pasteur
Microorganism Type 1 (Mahoney), Type 2 (MEFI) and Type 3 (Saukett)
Licensed
Licensed
Recommendations Three s.c. injections (0.5 mL) administered at intervals of eight weeks, followed by a fourth injection of 0.5 mL approximately 12 months after the third injection. In infancy the primary schedule is usually integrated with DPT (Diphtheria and Tetanus Toxoids and Pertussis Vaccine) immunisation, beginning at 8 to 12 weeks of age.
Ingredients Formaldehyde, Neomycin, Polymyxin B, Streptomycin, Bovine (cow) serum, Medium 199, Virus: polio, African green monkey kidney cells
Product Descriptions

IPOL® (IPV) Polio Vaccine Inactivated
Manufacturer Aventis Pasteur
Microorganism Polio-virus types 1, 2, and 3
Licensed 12/21/1990
Recommendations 5 injections at 2, 4, 6 and boosters at 18 months and at 4-6 years of age. Booster dose prior to international travel.
Ingredients Formaldehyde, Neomycin, 2 – Phenoxyethanol, Polymyxin B, Streptomycin, Stopper vial may contain dry latex rubber, Bovine (cow) serum, Virus: polio
Product Descriptions

Revaxis® (DT, IPV) Diphtheria, tetanus and inactivated polio, adsorbed
Manufacturer Sanofi Pasteur MSD Limited
Microorganism The bacterial toxins of Corynebacterium diphtheriae and Clostridium tetani, and polio virus
Licensed 06/03/2003
Recommendations Children from the age of six years, adolescents and adults.
Ingredients Aluminum hydroxide, Formaldehyde, Neomycin, 2 – Phenoxyethanol, Polymyxin B, Polysorbate 80, Streptomycin, Diphtheria toxoid, Tetanus toxoid, Virus: polio
Product Descriptions http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp?documentid=15259

Tetravac® Diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine, adsorbed
Manufacturer Aventis Pasteur
Microorganism
Licensed
Recommendations Primary immunisation can be given as 3 doses at an interval of 1-2 months starting at the age of 2 or 3 months or as 2 doses at an interval of 2 months starting at the age of 3 months and a third dose at the age of 12 months. A fourth dose should be administered within the second year of life.
Ingredients Aluminum hydroxide, Formaldehyde, Glutaraldehyde, 2 – Phenoxyethanol, Filamentous hemagglutinin (FHA), Diphtheria toxoid, Tetanus toxoid, Sodium hydroxide, Medium 199, Virus: polio, Acetic acid, Pertussis Toxoid
Product Descriptions Package insert

Td Polio Adsorbed (Td, IPV) Tetanus, reduced diptheria and inactivated polio
Manufacturer Aventis Pasteur
Microorganism Polio Type 1 (Mahoney), Type 2 (M.E.F.1), and Type 3 (Saukett), Clostridium tetani, Corynebacterium diptheriae
Licensed 06/03/2003
Recommendations 3 injection at 0, 2, 8-14 months. Age 7 years or older.
Ingredients Formaldehyde, Neomycin, 2 – Phenoxyethano, Polymyxin B, Aluminum phosphate, Diphtheria toxoid, Tetanus toxoid, Virus: polio
Product Descriptions

Repavax (dTaP/IPV) Diphtheria, Tetanus, Pertussis (Acellular, Component) and Poliomyelitis (Inactivated) Vaccine, adjuvanted
Manufacturer Aventis Pasteur
Microorganism C. diphtheriae, C. tetani, B. pertussis, polio virus
Licensed 09/26/2006
Recommendations from the age of three years, as a booster.
Ingredients Formaldehyde, Neomycin, 2 – Phenoxyethanol, Polymyxin B, Polysorbate 80, Streptomycin, Pertussis toxin, Aluminum phosphate, Diphtheria toxoid, Tetanus toxoid, Virus: polio, Polyribosylribitol phosphate, African green monkey kidney cells
Product Descriptions Website: http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp?documentid=15256

QUADRACEL® (DTP, IPV) Diphtheria, tetanus, pertussis, adsorbed with poliomyelitis
Manufacturer Aventis
Microorganism C. Diphtheriae toxin, C. tetani toxin, B. pertussis, poliovirus type 1, 2, and 3
Licensed
Recommendations 4 i.m. injections at 2, 4, 6, and 18 months of age. Not recommended for those over 7 years of age.
Ingredients Formaldehyde, Neomycin, 2 – Phenoxyethanol, Polymyxin B, Polysorbate 80, Pertussis toxin, Filamentous hemagglutinin (FHA), Pertactin, Tetanus, Aluminum phosphate, Diphtheria toxoid, Bovine (cow) serum
Product Descriptions Package insert

Pentacel® (HiB, DPT, IPV) ActHIB® reconstituted with QUADRACEL®
Manufacturer Aventis (Canada)
Microorganism H. influenzae virus type b, C. diphtheriae, C. tetani, B. pertussis, and polio virus
Licensed 09/26/2005
Recommendations 4 injections at 2, 4, 6, and 18 months of age, not for use with persons age 7 or older.
Ingredients Formaldehyde, Neomycin, 2 – Phenoxyethanol, Polymyxin B, Polysorbate 80, Pertussis toxin, Filamentous hemagglutinin (FHA), Pertactin, Aluminum phosphate, Diphtheria toxoid, Tetanus toxoid, Bovine (cow) serum, Virus: polio, Haemophilus influenzae B, Polyribosylribitol phosphate
Product Descriptions Package insert

Pediarix™ (HBV, DTaP, IPV) and inactivated Polio
Manufacturer GlaxoSmithKline
Microorganism C. diphtheriae, C. tetani and B. pertussis, H. influenzae virus type b and the polio virus
Licensed 12/13/2002
Recommendations 3 i.m. injections in infants as early as 6 weeks of age, to 7 years of age.
Ingredients Aluminum hydroxide, Formaldehyde, Neomycin, Polymyxin B, Polysorbate 80, Thimerosal, Yeast, Pertussis toxin, Filamentous hemagglutinin (FHA), Pertactin, Stopper vial may contain dry latex rubber, Tetanus, Sodium chloride, Virus: polio
Product Descriptions Package insert

Pediacel (DTaP, IPV, HiB) Diphtheria, tetanus, five component acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine, adsorbed
Manufacturer Aventis Pasteur (Europe)
Microorganism C. diptheriae, C. tetani, B. pertussis, polio virus, H. influenzae B
Licensed 10/10/2002
Recommendations Three i.m. injections at 2, 3, 4 months with at least one month between injections.
Ingredients Aluminum hydroxide, Formaldehyde, Glutaraldehyde, Neomycin, 2 – Phenoxyethanol, Polymyxin B, Polysorbate 80, Streptomycin, Pertussis toxin, Aluminum phosphate, Diphtheria toxoid, Tetanus toxoid, Virus: polio, Haemophilus influenzae B, Polyribosylribitol phosphate, African green monkey kidney cells
Product Descriptions Web site: http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp?documentid=15257

Infanrix Penta (DTaP, HBV, IPV) Diphtheria, tetanus, acellular, hepatitis B, inactivated polio
Manufacturer GlaxoSmithKline
Microorganism C. diphtheria and C. tetani toxoid, B. pertussis, Hepatitus B, Polio virus Type 1 (Mahoney strain) Type 2 (MEF-1 strain), Type 3 (Saukett strain), adsorbed
Licensed 10/23/2000
Recommendations 4 injections at 2, 3, 4, and 11 or 12 months, interval of at leasts 1 month between doses. Not intended for children over 3 years of age.
Ingredients Aluminum hydroxide, 2 – Phenoxyethanol, Pertussis toxin, Filamentous hemagglutinin (FHA), Pertactin, Aluminum phosphate, Diphtheria toxoid, Tetanus toxoid, Virus: Hepatitis B, Medium 199, Virus: polio
Product Descriptions EMEA Document

Infanrix Hexa (DTaP, IPV, Hib, HBV) Diptheria, tetanus, pertussis, H. influenzae B, Hepatitis B and inactivated polio virus
Manufacturer GlaxoSmithKline (France)
Microorganism Diphtheria, tetanus, and pertussis toxoids, hepatitis B, Poliovirus Type 1 (Mahoney strain), Type 2 (MEF-1 strain), Type 3 (Saukett strain)
Licensed 10/26/2000
Recommendations Three i.m. injections at 2, 3, 4 months.
Ingredients Aluminum hydroxide, 2 – Phenoxyethanol, Pertussis toxin, Filamentous hemagglutinin (FHA), Pertactin, Sodium chloride, Aluminum phosphate, Diphtheria toxoid, Tetanus toxoid, Virus: Hepatitis B, Medium 199, Virus: polio, Haemophilus influenzae B, Lactose
Product Descriptions EMEA Document

Hexavac (DTaP, IPV, HBV, Hib) Diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted
Manufacturer Aventis Pasteur MSD
Microorganism C. Diphtheriae, C. tetani, B. pertussis, polio virus, hepatitis B and Haemophilus influenzae type b
Licensed 10/26/2000
Recommendations One i.m. injection for infants (from 2 to 12 months of age) with booster vaccination in toddlers (from 12 to 18 months of age).
Ingredients Aluminum hydroxide, Formaldehyde, Sucrose, Pertussis toxin, Filamentous hemagglutinin (FHA), Diphtheria toxoid, Tetanus toxoid, Bovine (cow) serum, Sodium hydroxide, Virus: Hepatitis B, Medium 199, Haemophilus influenzae B, Acetic acid, Trometamol, Sodium hydrogen carbonate, Potassium dihydrogen phosphate, Disodium phosphate dehydrate
Product Descriptions Suspension Press Release

DT – Polio Diptheria, tetanus and polio
Manufacturer Sanofi Pasteur
Microorganism The bacterial toxins of C. diptheriae and C. tetani and polio virus
Licensed Discontinued – 2005
Recommendations Five injections at 2, 4, 6 and 18 months and 4-6 years of age. Boosters of tetanus and diphtheria are recommended every 10 years.
Ingredients Formaldehyde, Neomycin, 2 – Phenoxyethanol, Polymyxin B, Aluminum phosphate
Product Descriptions